HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites
 

Bristol Myers Squibb NEWS

NFE/5.0en-USnews-webmaster@google.com2019 Google Inc.Wed, 13 Feb 2019 15:27:47 GMTGoogle News
Bristol-Myers Squibb reduces Russian range due to pressure of local co  The Pharma Letter

US pharma major Bristol-Myers Squibb (NYSE: BMS) is reducing its Russian portfolio of drugs by the suspension of the imports of some of them to the local ...

The Pharma Letter
Bristol-Myers Squibb (BMY) Announces Opdivo Plus Low-Dose Yervoy Demonstrates Continued Survival Benefit at 30-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic RCC  StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Bristol-Myers Squibb Company (NYSE: BMY) ...

StreetInsider.com
Why Bristol-Myers Squibb Stock Sank By 15.2% in 2018  Motley Fool

Bristol's inability to compete against Merck in front-line lung cancer weighed heavily on its shares last year.

Motley Fool
Celgene Highlights What Bristol-Myers Squibb Is Getting  Motley Fool

Celgene (NASDAQ:CELG) is on track to become part of Bristol-Myers Squibb (NYSE:BMY), but its earnings still matter for current shareholders because the ...

Motley Fool
Starboard Value Is to Take Stake in Bristol-Myers Squibb  Bloomberg

Starboard Value has taken a stake in Bristol-Myers Squibb, the pharmaceutical giant that agreed to acquire Celgene Corp. in a record $74 billion deal last month ...

Bloomberg
What To Expect From Bristol-Myers Squibb's Q4  Forbes

Bristol-Myers Squibb (NYSE:BMY) is scheduled to announce its Q4 earnings on January 24. We expect the company to post steady top line and bottom line ...

Forbes
Is Bristol-Myers Squibb a Bargain Now?  The Motley Fool

The big pharma stock has taken a pounding for good reasons, but it looks like the punishment has gone too far.

The Motley Fool
Bristol-Myers Squibb Stock Issued For Celgene: I Plan To Keep It  Seeking Alpha

The Bristol-Myers Squibb acquisition undervalues Celgene. Bristol-Myers would also be undervalued post-deal at current prices. I am inclined to keep the BMY ...

Seeking Alpha
Bristol-Myers Squibb Company 2018 Q4 - Results - Earnings Call Slides  Seeking Alpha

The following slide deck was published by Bristol-Myers Squibb Company in conjunction with their 2018 Q4 earnings call.

Seeking Alpha
BMS can breathe easier now: Celgene's Revlimid has escaped a big patent challenge  FiercePharma

When Bristol-Myers Squibb picked up Celgene in one of biopharma's biggest deals ever last month, investors tagged one big risk: Celgene's megablockbuster ...

FiercePharma
Starboard said to take stake in Bristol-Myers Squibb  Seeking Alpha

Starboard Value took a stake in Bristol-Myers Squibb (BMY) ahead of the company's planned acquisition of Celgene (CELG), sources tell Bloomberg. The size o.

Seeking Alpha
Bristol-Myers Squibb 2018 Full-Year Financials: "Superior Commercial Performance"  BioSpace

Any news in Bristol-Myers Squibb's 2018 full-year financial report is going to tend to get lost in the shadow of its $74 billion acquisition of Celgene. Still, it looked ...

BioSpace
Faber: Hedge fund Starboard has not contacted Bristol-Myers Squibb  CNBC

CNBC's David Faber reports that activist hedge fund Starboard Value has not contacted Bristol-Myers Squibb, as Bloomberg reported previously.

CNBC
'Most feared' activist investor in America has zeroed in on Bristol-Myers Squibb. Is he planning to derail the $74B Celgene buyout?  Endpoints News

The “most feared man in corporate America” has just set his sights on Bristol-Myers Squibb. And that may make some of Bristol-Myers more than a little ...

Endpoints News
Bristol-Myers Squibb beats by $0.10, beats on revenue  Seeking Alpha

Bristol-Myers Squibb (BMY): Q4 Non-GAAP EPS of $0.94 beats by $0.10; GAAP EPS of $0.73 beats by $0.12. Revenue of $5.97B (+9.5% Y/Y) beats by $20M.

Seeking Alpha
PHOTOS: Looking back at the construction of, and life at, Bristol-Myers Squibb in Wallingford  Meriden Record-Journal

PHOTOS: Looking back at the construction of, and life at, Bristol-Myers Squibb in Wallingford-

Meriden Record-Journal
Bristol-Myers Squibb Co (BMY) Position Boosted by Advisor Partners LLC  Baseball Daily News

Advisor Partners LLC increased its position in Bristol-Myers Squibb Co (NYSE:BMY) by 5.7% in the fourth quarter, according to the company in its most recent ...

Baseball Daily News
Congressmen urge DOJ to scrutinize Bristol-Myers Squibb - Celgene tie-up  Seeking Alpha

U.S. Representatives Peter Welch (D-VT At large) and Francis Rooney (R-FL 19th District) have sent a letter to the Federal Trade Commission and the Departm.

Seeking Alpha
Eli Lilly, Loxo Make More Sense Than Bristol Myers, Celgene  Seeking Alpha

The Bristol Myers/Celgene deal is a leveraged buy out at the end of business cycle and both are mature firms, neither lacking for economies of scale. The Eli Li.

Seeking Alpha
Global Urological Cancer Drugs Market 2018 Roche Healthcare, Novartis, Bristol-Myers Squibb, Celgene Corporation, Ipsen  TheCells

The global “Urological Cancer Drugs” Market research report gives point to point breakdown along with the data of Urological Cancer Drugs markets analytical ...

TheCells
Should Analyst help in decision? Bristol-Myers Squibb Company (BMY)  Voice Of Analysts

Bristol-Myers Squibb Company (BMY) stock managed performance -1.47% over the last week and switched with performance of 4.99% throughout past one ...

Voice Of Analysts
Bristol-Myers Squibb (BMY) Announces European Commission Approval for Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab)  StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Bristol-Myers Squibb Company (NYSE: BMY) ...

StreetInsider.com
Taisho Pharmaceutical Holdings Co., Ltd.'s $1.6 Billion Acquisition of Bristol-Myers Squibb's UPSA consumer health business – Global Legal Chronicle  Global Legal Chronicle

Deutsche Bank Securities, Inc. and Jefferies LLC acted as exclusive financial advisors to Bristol-Myers Squibb. Kirkland & Ellis LLP, Freshfields Bruckhaus ...

Global Legal Chronicle
The Bristol-Myers Celgene Deal, And Other Ideas  Seeking Alpha

This week's Idea Guide breaks down our coverage of the Bristol-Myers/Celgene deal. Our contributors express a mix of investor fatigue, excitement about the ...

Seeking Alpha
Bristol-Myers Squibb Company (BMY): Is this Stock Safe to Play in?  News Stays On Track

Bristol-Myers Squibb Company (BMY):. Bristol-Myers Squibb Company (BMY) stock moved up 1.28% in contrast to its 20 day moving average displaying ...

News Stays On Track
Amid protests, Wallingford PZC denies warehouses proposal for BMS site  Meriden Record-Journal

By Lauren Takores. WALLINGFORD — The Planning and Zoning Commission voted Monday night to deny a special permit to build two warehouses on the ...

Meriden Record-Journal
BMS in Wallingford to be demolished, but future of property is unclear  Meriden Record-Journal

WALLINGFORD — After the Planning and Zoning Commission rejected a redevelopment plan for the former Bristol-Myers Squibb site Monday, the property ...

Meriden Record-Journal
Global Bipolar Disorder Therapeutics Market 2019 – AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Astellas Pharma, Allergan – Global Up  GloballUp

The Global Bipolar Disorder Therapeutics Market report covers the market landscape and its growth prospects over the coming years and discussion of the key ...

GloballUp
Bristol-Myers Squibb Company (BMY) Mass Index Breaches Key Level  Richland Standard

Bristol-Myers Squibb Company (BMY) shares might have a significant move ahead as the Mass Index volatility reading has dropped below 26.5. Mass Index.

Richland Standard
No Starboard stake in Bristol-Myers yet - CNBC  Seeking Alpha

CNBC's David Faber says that, contrary to a Bloomberg report, his sources say institutional investor Starboard Value has not spoken with Bristol-Myers Squi.

Seeking Alpha
BMS talks up Celgene merger to divert Opdivo disappointment  FiercePharma

Bristol-Myers Squibb executives did their best to talk up the six near-term product launches they're expecting from its $74 billion merger with Celgene during the ...

FiercePharma
Bristol-Myers and Eli Lilly Want to Borrow for M&A, but Could See Credit Downgrades  Barron's

Bristol-Myers Squibb and Lilly plan to take on debt to pay for big deals, but S&P Ratings analysts expect to downgrade both companies if the acquisitions are ...

Barron's
Global Signal Transduction Inhibitors Market 2019: Bristol-Myers Squibb, Roche, AstraZeneca, GSK, Novartis, Amgen  Industry News Press

Global Signal Transduction Inhibitors Market 2019 report offers incisive information in a detailed manner related to key aspects of the market that are expected to ...

Industry News Press
Technical Analysis: Bristol-Myers Squibb Company (BMY)  Nasdaq Click

Bristol-Myers Squibb Company (BMY) stock value sealed its day with gain 0.34% and wind up at the price of $50.22, its 52 week- top value and replaced ...

Nasdaq Click
Momenta Pharmaceuticals, Inc. v, Bristol-Myers Squibb Co. (Fed. Cir. 2019)  JD Supra

The Federal Circuit has on several occasions taken the opportunity to address (and in doing so, flesh out) the requirements for Article III standing to appeal an ...

JD Supra
U.S. STOCKS ON THE MOVE-Evolus, Papa John's, Bristol-Myers Squibb, Amazon  Nasdaq

The Morning News Call newsletter:. U.S. stocks treaded water on Monday as a tech boost was offset by declines in energy companies, as investors wait.

Nasdaq
An Eye on Trend-Spotting Tool – Bristol-Myers Squibb Company (NYSE: BMY)  Alpha Beta Stock

Bristol-Myers Squibb Company (NYSE: BMY) stock encountered a rapid change of -0.24% in the last hour of Monday's trading session. The stock settled the final ...

Alpha Beta Stock
EMA OK's Bristol-Myers Squibb's Opdivo + Yervoy for first-line kidney cancer  Seeking Alpha

The European Commission approves Bristol-Myers Squibb's (BMY) combination of Opdivo (nivolumab) and low-dose Yervoy (ipilimumab) for the first-line ...

Seeking Alpha
Celgene down 3%  Seeking Alpha

Celgene ([[CELG]] -2.8%) is down on modestly higher volume in apparent to response to the potential involvement of activist investor Starboard Value via a.

Seeking Alpha
Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market 2019 – Bristol-Myers Squibb,Novartis,Sanofi Aventis – Global Up  GloballUp

The Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market report covers the market landscape and its growth prospects over the coming ...

GloballUp
Here’s What Starboard Might Be Planning for Papa John’s and Bristol-Myers  Barron's

The hedge fund has a history in both restaurants and in health care. It isn't clear what Starboard CEO Jeff Smith plans this time, but investors should take note.

Barron's
For BeiGene, Bristol-Celgene deal is poised to have big ripple effects  STAT

SAN FRANCISCO — Celgene is famous for cultivating a constellation of biotech partners — companies whose fortunes are poised to be shifted by last month's ...

STAT
Bristol-Myers Stock Could Get Hit By Donald Trump’s Drug-Price Plan  Barron's

President Donald Trump made lower prescription drug prices one of his top goals in his State of the Union speech on Tuesday night. The main proposal he ...

Barron's
Global Recombinant Human Serum Albumin Market 2019 – Boehringer Ingelheim, Bristol-Myers Squibb, Celldex Therapeutics, Eli Liily  Market Reports

The report gives the research-based overview of Global Recombinant Human Serum Albumin Market 2018 and estimates future industry trends throughout the ...

Market Reports
Amarin Corporation PLC (NASDAQ:AMRN), Bristol-Myers Squibb Company (NYSE:BMY) - Pharma Catches Another Case Of M&A Fever  Benzinga

Is it 2018 all over again? While most investors will probably flinch at the suggestion, history is repeating itself somewhat in the pharmaceutical industry ...

Benzinga
Merck/Pfizer up the pressure on BMS in first-line kidney cancer  pharmaphorum

The FDA has started a speedy review of Merck KGaA and Pfizer's new combination regimen for advanced kidney cancer, setting up a possible approval in June ...

pharmaphorum
Bristol Advisors LLC Purchases New Stake in Bristol-Myers Squibb Co (NYSE:BMY)  Fairfield Current

Bristol Advisors LLC bought a new stake in Bristol-Myers Squibb Co (NYSE:BMY) during the 4th quarter, according to the company in its most recent 13F filing ...

Fairfield Current
Smaller groups await Bristol-Myers Squelgene fallout  Vantage

As the dust settles on Bristol-Myers Squibb's takeout of Celgene it is not just big pharma that is left wondering where it now stands. A slew of smaller companies ...

Vantage
Protein Phosphatase Market Analysis (2019 – 2025)| Ampio Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Cyano Biotech GmbH, Lixte Biotechnology Holdings  Fashion Herald

The global Galantamine Hydrobromide market report offers fine intelligence that prepares market players to compete well against their toughest competitors on ...

Fashion Herald
Global Schizophrenia Drugs Market 2019 – Johnson & Johnson, Bristol-Myers Squibb, Otsuka Pharma, AstraZeneca – TheTokenClock  TheTokenClock

The Global Schizophrenia Drugs Market report provides detailed insight, industry knowledge, market forecasts, and analytics to make confident capital ...

TheTokenClock
Immune Thrombocytopenic Purpura Therapeutics Market 2019 – Amgen Inc., Baxalta Incorporated, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eisai  reportsherald.com

Global Immune Thrombocytopenic Purpura Therapeutics Market highlights the major aspects of the market in terms of historic data, current market situations, ...

reportsherald.com
EMA Under Review for Bristol-Myers Squibb Company (NYSE:BMY): 20 Day is Now 49.86026  Felton News

There are many traders who think that proper psychology is one of the most important aspects of becoming successful in the stock market. Traders may need to.

Felton News
Congressmen to regulators: BMS-Celgene merger will stifle competition and raise drug prices  FiercePharma

U.S. Representatives Peter Welch and Francis Rooney are urging the Federal Trade Commission and Department of Justice to take a close look at ...

FiercePharma
Better Than All The Rest : – Bristol-Myers Squibb Company, (NYSE: BMY)  Nyse NewsToday

The Relative Strength Index (RSI) is a technical indicator used in the analysis of financial markets. It is intended to chart the current and historical strength or ...

Nyse NewsToday
On second thought, Big Pharma CEOs decide to show up at Senate pricing hearings  FiercePharma

Last week, Sen. Charles Grassley, R-Iowa, vowed to haul pharma CEOs into Senate hearings on drug prices. Now, CEOs for Merck, Pfizer, Sanofi, Bristol-Myers ...

FiercePharma
Global Pigmented Villonodular Synovitis Drug Market 2019 – Bristol-Myers Squibb Co, F. Hoffmann-La Roche Ltd, Novartis AG, Plexxikon Inc  Industry News Press

The Global Pigmented Villonodular Synovitis Drug Market report inspects future trends for supply, demand, and market growth rate, prices, market size, ...

Industry News Press
Wallingford wetlands permits stand as BMS site owner regroups  Meriden Record-Journal

WALLINGFORD — Calare Properties can reapply for a site plan permit for the former Bristol-Myers Squibb campus at any time, regardless of whether it's a new, ...

Meriden Record-Journal
Clorox Stock Jumps, Bristol-Myers Gains and 3 More Monday Morning Movers  Barron's

Measured Monday. Dow Jones Industrial Average futures are fractionally higher, while the S&P 500 is flat, and Nasdaq Composite off less than 0.1%.

Barron's
Global Rheumatology Therapeutics Market Outlook 2019-2025: AbbVie, Pfizer, Bristol-Myers Squibb Company, Merck & Co, Amgen  TheGamingRadar

The “Rheumatology Therapeutics Market” report contains wide-ranging statistical surveying for Rheumatology Therapeutics which empowers the client to break ...

TheGamingRadar
Global Testicular Cancer Drugs Market Outlook, 2019-2023 with Baxter, Bristol-Myers Squibb, Eli Lilly, Pfizer, and Teva Pharmaceutical Leading - ResearchAndMarkets.com  Business Wire

DUBLIN--(BUSINESS WIRE)--The "Global Testicular Cancer Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Business Wire
Investigation Report on China's Entecavir (Bristol-Myers Squibb) Market, 2018-2022 Featuring Chia Tai Tianqing, Sino-American Shanghai Squibb, Jiangxi Qingfeng, Suzhou Dawnrays, & Fujian Cosunter  GlobeNewswire

Dublin, Jan. 17, 2019 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Entecavir Market, 2018-2022" report has been added to ...

GlobeNewswire
Forget Bristol-Myers: Regeneron takes on Merck for the heavyweight title in non-small cell lung cancer  Endpoints News

Regeneron may have been the 6th biopharma company to land an initial approval for a PD-1/L1 therapy, but they're clearly not settling for anything close to a ...

Endpoints News
Bristol-Myers Squibb Company (BMY) Punches One Year New Low  Wall Street Morning

Technical analysis of Bristol-Myers Squibb Company (BMY) stock is the study of technical indicators and past trends. For technical analysis of stock and trends ...

Wall Street Morning
Global Cancer Treatment Drugs Market 2019 – Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda  Bitcoin Journal

The report gives the research-based overview of Global Cancer Treatment Drugs Market 2018 and estimates future industry trends throughout the forecast ...

Bitcoin Journal
Bristol Myers Squibb Co Com (BMY) Shareholder Lucas Capital Management Lowered Its Holding by $1.25 Million as Share Price Declined; Vista Capital Partners Cut Jewett Cameron Trading LTD Com New (JCTCF) Position by $356,536  The Moveefy

Lucas Capital Management decreased its stake in Bristol Myers Squibb Co Com (BMY) by 32.16% based on its latest 2018Q3 regulatory filing with the SEC.

The Moveefy
Global CD40 Ligand Market Insights 2019-2025: Biogen, Inc., Bristol-Myers Squibb Company, eTheRNA Immunotherapies NV, ImmuNext  Industry News Press

The market report, named “CD40 Ligand Market” Forecast 2019–2025 is voluminous research dependent on CD40 Ligand market that conveys the sober ...

Industry News Press
New Study On Arterial Thrombosis Drug Market 2019-2025| Astellas Pharma, Bayer AG, Bristol-Myers Squibb Company, Eisai, Johnson & Johnson, Sanofi, Thromboserin  Industry Journal Pro

UpMarketResearch offers a latest published report on “Global Arterial Thrombosis Drug Market Industry Analysis and Forecast 2019-2025” delivering key ...

Industry Journal Pro
Know how Anticoagulants Drug Market 2019-2025 is growing rapidly| Leading Key Players Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), Portola Pharmaceuticals, Roche (Switzerland), Abbott (US), Siemens  openPR

UpMarketResearch offers a latest published report on “Global Anticoagulants Drug Market Industry Analysis and Forecast 2019-2025” delivering key insights ...

openPR
BMS Withdraws Nivolumab/Ipilimumab Application in TMB-High NSCLC  Targeted Oncology

Bristol-Myers Squibb (BMS) has announced its decision to withdraw a supplemental biologics license application (sBLA) currently with the FDA seeking frontline ...

Targeted Oncology
Global Non Receptor Tyrosine Protein Kinase TYK2 Market 2019-2025| Array BioPharma, Bristol-Myers Squibb, Nimbus Therapeutics, Pfizer, Portola Pharmaceuticals, Sareum Holdings Plc  Industry Journal Pro

UpMarketResearch offers a latest published report on “Global Non Receptor Tyrosine Protein Kinase TYK2 Market Industry Analysis and Forecast 2019-2025” ...

Industry Journal Pro
Tauopathies Treatment Market to Set Remarkable Growth in Future : Bristol-Myers Squibb, Selvita, SK Biopharmaceuticals, Chronos Therapeutics - Press Release  Digital Journal

If you are involved in the Global Tauopathies Treatment industry or aim to be, then this study will provide you inclusive point of view. It's vital you keep your ...

Digital Journal
Short Interest Spikes in a Couple Major Pharma Stocks  24/7 Wall St.

The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.

24/7 Wall St.
Global Antidiabetics Market Insight Report 2018 – Bioton SA, Bristol-Myers Squibb, Sanofi-Aventis, Oramed Pharmaceuticals  Industry News Source

The Market Research Store report is a collective informative report that goes through the fundamental characteristics of the Market Research Store, essential to ...

Industry News Source
Essex Financial Services Decreased Bristol Myers Squibbco (BMY) Position as Stock Price Declined; Holder Grandfield & Dodd Boosted Cognizant Technology Solutio (CTSH) Position  The Hi New Ulm

Essex Financial Services Inc decreased its stake in Bristol Myers Squibbco (BMY) by 26.4% based on its latest 2018Q3 regulatory filing with the SEC. Essex ...

The Hi New Ulm
Vitiligo Drug Market Analysis (2019 – 2025)| Aclaris Therapeutics Inc, Arrien Pharmaceuticals LLC, Bristol-Myers Squibb Co, Celgene Corp, Clinuvel Pharmaceuticals Ltd  Fashion Herald

The global Vitiligo Drug market report offers fine intelligence that prepares market players to compete well against their toughest competitors on the basis of ...

Fashion Herald
Seattle Genetics' Adcetris Gets EC Nod for Label Expansion  Zacks.com

Seattle Genetics' (SGEN) partner, Takeda Pharmaceutical receives EC approval for Adcetris in combination with AVD to treat adults with previously untreated ...

Zacks.com
Bristol-Myers Squibb Co (BMY) Shares Obtained by Benedict Financial Advisors Inc.  BharataPress

Benedict Financial Advisors Inc. boosted its stake in Bristol-Myers Squibb Co (NYSE:BMY) by 5.7% during the fourth quarter, according to the company in its ...

BharataPress
Bingham Osborn & Scarborough LLC Sold 1711 Shares of Bristol-Myers Squibb Co (BMY)  BharataPress

Bingham Osborn & Scarborough LLC reduced its holdings in shares of Bristol-Myers Squibb Co (NYSE:BMY) by 27.9% during the 4th quarter, ...

BharataPress
New Research: Bipolar Disorder Drugs Market | Top Players – AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly  TheTokenClock

A new research study from HTF MI with title Global Bipolar Disorder Drugs Market Research Report 2019 provides an in-depth assessment of the Bipolar ...

TheTokenClock
Cobblestone Capital Advisors LLC NY Has $906000 Holding in Bristol-Myers Squibb Co (BMY)  BharataPress

Cobblestone Capital Advisors LLC NY cut its stake in shares of Bristol-Myers Squibb Co (NYSE:BMY) by 3.1% in the 4th quarter, HoldingsChannel reports.

BharataPress
Global Melanoma Drugs Market 2019 Overview: Amgen, Bristol-Myers Squibb, Roche, Genentech, Janssen Biotech, Novartis  Industry News Source

The new research report entitled Global Melanoma Drugs Market 2019 provides a detailed and complete global coverage of Melanoma Drugs Market data from ...

Industry News Source
Global Oral Solid Dosage Pharmaceutical Formulation Market Key Player 2019 – AstraZeneca, Bristol-Myers Squibb  The Concepts News

The global “Oral Solid Dosage Pharmaceutical Formulation Market“ report delivers a comprehensive and systematic framework of the Oral Solid Dosage ...

The Concepts News
A Global Digital Media Network  Digital Journal

This press release was orginally distributed by SBWire. Edison, NJ -- (SBWIRE) -- 02/07/2019 -- A new business intelligence report released by HTF MI with title ...

Digital Journal
Global Paclitaxel Injection Market 2019 – Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura – TheTokenClock  TheTokenClock

The Global Paclitaxel Injection Market report present framework on market potential for each geological district in light of the growth rate, macroeconomic ...

TheTokenClock
Bemis INC (BMS) Stock Value Declined While Deprince Race & Zollo INC Trimmed by $11.14 Million Its Stake | Thorold News  Thorold News

Investors sentiment decreased to 0.86 in Q3 2018. Its down 0.05, from 0.91 in 2018Q2. It fall, as 32 investors sold BMS shares while 108 reduced holdings. 55.

Thorold News
Shedding Some Light on Quant Signals & Ratios: CVS Health Corporation (NYSE:CVS), Bristol-Myers Squibb Company (NYSE:BMY)  Martin Business Telegraph

In order to determine if a company is fairly valued, we can look at a number of different ratios and metrics. First off we'll take a look at the Price to.

Martin Business Telegraph
Hayden Royal LLC Purchases New Position in Bristol-Myers Squibb Co (BMY)  Baseball Daily News

Hayden Royal LLC purchased a new position in shares of Bristol-Myers Squibb Co (NYSE:BMY) during the 4th quarter, according to the company in its most ...

Baseball Daily News
Inflammatory Bowel Disease Market Analysis and Forecast by Type, Application and Top Manufactures (Bristol-Myers Squibb Company, Baxter International, Johnson & Johnson)  DD News Herald

Global Inflammatory Bowel Disease Market Research study which offers visions of detailed research on historic and recent market size along with the estimated ...

DD News Herald
Lawmakers want feds to look at how a Bristol-Celgene deal affects prices  STAT

They say the Federal Trade Commission and the Department of Justice should examine whether the takeover could reduce treatment options for patients.

STAT
ShareholderDemocracy.com: Six Top U.S. Pharmaceutical Companies to Feel the Heat on Runaway Drug Prices, as More Americans Get a Voice on Proxy Ballot Measures  Business Wire

In recent days the growing outrage over sky-high drug prices has attracted the attention of everyone from Bernie Sanders to President Trump in his Sta.

Business Wire
First National Trust Co Reduces Position in Bristol-Myers Squibb Co (BMY)  Baseball Daily News

First National Trust Co cut its holdings in Bristol-Myers Squibb Co (NYSE:BMY) by 6.6% in the 4th quarter, according to the company in its most recent filing with ...

Baseball Daily News
Bristol-Myers Squibb Co (NYSE:BMY) Shares Sold by Patten & Patten Inc. TN  PressOracle

Patten & Patten Inc. TN lowered its position in shares of Bristol-Myers Squibb Co (NYSE:BMY) by 72.2% in the fourth quarter, according to the company in its ...

PressOracle
Global Personalized Medicine Pm Market 2012-2022: Inventive Industry Growth by Top Companies: Qiagen Inc., Amgen Inc., GE Healthcare, Bristol-Myers Squibb  Eagle Chronicle

Global Personalized Medicine Pm Market report covers the segmentation arena, market secrets and regional retreats, size, share, growth analysis, trends and ...

Eagle Chronicle
Bristol (BMY) Shareholder Hgk Asset Management Has Decreased Its Position by $1.03 Million as Market Valuation Declined; Lockheed Martin (LMT) Stake Raised by Renaissance Group Llc  The Hi New Ulm

Hgk Asset Management Inc decreased its stake in Bristol (BMY) by 7.37% based on its latest 2018Q3 regulatory filing with the SEC. Hgk Asset Management Inc ...

The Hi New Ulm
Global Wound Care Sealants Market Insight Report 2018 – Cryolife, Davol, Pfizer, Genzyme, Ethicon, Bristol-Myers Squibb, Medtronic  Industry News Source

The global “Wound Care Sealants” market report exhibits the comprehensive information linked to the Wound Care Sealants market. The updated market report ...

Industry News Source
Ahead of Bristol Myers purchase, Celgene partners with Boston cancer startup  Boston Business Journal

Atlas Venture-backed Kyn Therapeutics hopes to create drugs that reverse the effects of a metabolite called kynurenine, which cancer cells use to suppress the ...

Boston Business Journal
Global Glioblastoma Multiforme Therapeutics Market Key Player 2019 – Arbor Pharmaceuticals, Bristol-Myers Squibb, Eisai  Honest Version

The global “Glioblastoma Multiforme Therapeutics Market“ report delivers a comprehensive and systematic framework of the Glioblastoma Multiforme ...

Honest Version
Tiny Israeli firm touts cancer cure  Seeking Alpha

Delivering a healthy dose of hyperbole, Dan Aridor, Chairman of Israel-based biotech Accelerated Evolution Biotechnologies Ltd., says his company will be o.

Seeking Alpha
 

Bristol Myers Squibb Videos

Bristol-Myers Squibb
13:56:15
Bristol-Myers Squibb
Bristol-Myers and Celgene CEOs talk acquisition deal
16:29:14
Bristol-Myers and Celgene CEOs talk acquisition deal
Bristol-Myers Squibb to acquire Celgene for $74B
13:06:42
Bristol-Myers Squibb to acquire Celgene for $74B
Bristol-Myers Squibb Company Mission | Bristol-Myers Squibb
19:32:28
Bristol-Myers Squibb Company Mission | Bristol-Myers Squibb
Faber: Hedge fund Starboard Value has not contacted Bristol-Myers Squibb
18:39:52
Faber: Hedge fund Starboard Value has not contacted Bristol-Myers Squibb
Bristol-Myers' Planned Purchase of Celgene Gets 2019 Off to Hot M&A Start
22:40:37
Bristol-Myers' Planned Purchase of Celgene Gets 2019 Off to Hot M&A Start
Bristol-Myers to buy Celgene in $74B deal
12:40:07
Bristol-Myers to buy Celgene in $74B deal
Why Jim Cramer Is Worried About Bristol-Myers Bid to Buy Celgene
16:31:15
Why Jim Cramer Is Worried About Bristol-Myers Bid to Buy Celgene
Bristol-Myers' Celgene acquisition is the start of pharmaceutical industry mergers: analyst
17:08:42
Bristol-Myers' Celgene acquisition is the start of pharmaceutical industry mergers: analyst
BMS Employee Tour
00:59:49
BMS Employee Tour
 

Bristol Myers Squibb Images

Access Celgene's Global Office Network | Celgene Corp.
Access Celgene's Global Office Network | Celgene Corp.
Introduction to Immuno-Oncology for Oncologists - ppt ...
Introduction to Immuno-Oncology for Oncologists - ppt ...
Motion Graphics Studio Leftchannel Unveils Sophisticated ...
Motion Graphics Studio Leftchannel Unveils Sophisticated ...
Amylin Pharmaceuticals - Wikipedia
Amylin Pharmaceuticals - Wikipedia
DailyMed - EMPLICITI- elotuzumab injection, powder ...
DailyMed - EMPLICITI- elotuzumab injection, powder ...
Neuropathic Pain Market: Global Industry Demand, Market ...
Neuropathic Pain Market: Global Industry Demand, Market ...
Roy DiTosti Photo Gallery
Roy DiTosti Photo Gallery
RxResource.org
RxResource.org
A First in Lung Cancer: Immunotherapy Improves Survival
A First in Lung Cancer: Immunotherapy Improves Survival
Torsten Kanisch - Senior Executive Officer, Senior ...
Torsten Kanisch - Senior Executive Officer, Senior ...
 

Bristol Myers Squibb WebSites